摘要
目的:在用细胞周期蛋白(cyclin)B1作为HeLa细胞周期G1期时相的阴性标志物时,发现呈阳性结果,为此,对细胞周期蛋白B在细胞的M期向G1期过渡中的作用做进一步探讨。方法:分别用诺考达唑(nocodazole)和离心淘洗的方法同步化HeLa细胞,用Western印迹方法检测细胞周期蛋白B的存在。结果:用诺考达唑阻断细胞于M期,然后释放4h所得的G1期细胞中有细胞周期蛋白B,而离心淘洗的方法所得G1期细胞中没有细胞周期蛋白B。结论:(1)诺考达唑阻断细胞于M期后,可影响细胞周期蛋白B1在M期后期的降解;(2)细胞周期蛋白B1的降解对于HeLa细胞由M期向G1期过渡并不是必需的,可能还有别的蛋白质参与;(3)采用药物阻断的方法同步化细胞,对细胞的生理、生化活动有潜在的影响。
Objective: Cyclin B is first synthesized during S phase, accumulates to complexes with p34cdc2 as cells approach the G2 to M transition, and is abruptly degraded during mitosis. However, early G1 phase HeLa cells obtained by releasing the M phase cells (treated by nocodazole) have cyclin B1 protein, so it is necessary to further study the role of cyclin B in M→G1 transition. Methods: Two types of methods were used to synchronize HeLa G1 phase cells, i.e, by releasing M phase cells (arrested by nocodazole) and by centrifugal elutriation. Their cyclin B1 protein levels were detected by Western blotting analysis. Results: There are cyclin B1 protein in the G1 phase cells obtained by releasing M phase cells, but the cyclin B1 was undetectable from the G1 cells collected by centrifugal elutriation. Conclusion: (1) Nocodazole can inhibit cyclin B1 degradation at the metaphaseanaphase transition;(2) The degradation of cyclin B1 is not essential for the metaphaseanaphase transition of HeLa cells; (3) Drugs that used to synchronize cells may have potential effect on the cell physiology.
出处
《军事医学科学院院刊》
CSCD
北大核心
1998年第3期184-186,190,共4页
Bulletin of the Academy of Military Medical Sciences